117 related articles for article (PubMed ID: 11008129)
1. Effects of resveratrol on the autophosphorylation of phorbol ester-responsive protein kinases: inhibition of protein kinase D but not protein kinase C isozyme autophosphorylation.
Stewart JR; Christman KL; O'Brian CA
Biochem Pharmacol; 2000 Nov; 60(9):1355-9. PubMed ID: 11008129
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol antagonizes EGFR-dependent Erk1/2 activation in human androgen-independent prostate cancer cells with associated isozyme-selective PKC alpha inhibition.
Stewart JR; O'Brian CA
Invest New Drugs; 2004 Apr; 22(2):107-17. PubMed ID: 14739659
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol preferentially inhibits protein kinase C-catalyzed phosphorylation of a cofactor-independent, arginine-rich protein substrate by a novel mechanism.
Stewart JR; Ward NE; Ioannides CG; O'Brian CA
Biochemistry; 1999 Oct; 38(40):13244-51. PubMed ID: 10529197
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of protein kinase D by resveratrol.
Haworth RS; Avkiran M
Biochem Pharmacol; 2001 Dec; 62(12):1647-51. PubMed ID: 11755118
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of protein kinase C by resveratrol.
Slater SJ; Seiz JL; Cook AC; Stagliano BA; Buzas CJ
Biochim Biophys Acta; 2003 Jan; 1637(1):59-69. PubMed ID: 12527408
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol inhibits phorbol ester and UV-induced activator protein 1 activation by interfering with mitogen-activated protein kinase pathways.
Yu R; Hebbar V; Kim DW; Mandlekar S; Pezzuto JM; Kong AN
Mol Pharmacol; 2001 Jul; 60(1):217-24. PubMed ID: 11408617
[TBL] [Abstract][Full Text] [Related]
7. Interaction of protein kinase C with filamentous actin: isozyme specificity resulting from divergent phorbol ester and calcium dependencies.
Slater SJ; Milano SK; Stagliano BA; Gergich KJ; Curry JP; Taddeo FJ; Stubbs CD
Biochemistry; 2000 Jan; 39(2):271-80. PubMed ID: 10630986
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase D (PKD): a novel target for diacylglycerol and phorbol esters.
Rozengurt E; Sinnett-Smith J; Van Lint J; Valverde AM
Mutat Res; 1995 Dec; 333(1-2):153-60. PubMed ID: 8538623
[TBL] [Abstract][Full Text] [Related]
9. Evidence that protein kinase C-alpha activation is a critical event in phorbol ester-induced multiple drug resistance in human colon cancer cells.
Gravitt KR; Ward NE; Fan D; Skibber JM; Levin B; O'Brian CA
Biochem Pharmacol; 1994 Jul; 48(2):375-81. PubMed ID: 8053934
[TBL] [Abstract][Full Text] [Related]
10. P2X7 receptors activate protein kinase D and p42/p44 mitogen-activated protein kinase (MAPK) downstream of protein kinase C.
Bradford MD; Soltoff SP
Biochem J; 2002 Sep; 366(Pt 3):745-55. PubMed ID: 12057008
[TBL] [Abstract][Full Text] [Related]
11. Regulation of protein kinase D by multisite phosphorylation. Identification of phosphorylation sites by mass spectrometry and characterization by site-directed mutagenesis.
Vertommen D; Rider M; Ni Y; Waelkens E; Merlevede W; Vandenheede JR; Van Lint J
J Biol Chem; 2000 Jun; 275(26):19567-76. PubMed ID: 10867018
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase C-alpha is multiply phosphorylated in response to phorbol ester stimulation of PC12 cells.
Gatti A; Wang X; Robinson PJ
Biochim Biophys Acta; 1996 Aug; 1313(2):111-8. PubMed ID: 8781558
[TBL] [Abstract][Full Text] [Related]
13. Activation loop phosphorylation controls protein kinase D-dependent activation of nuclear factor kappaB.
Storz P; Döppler H; Toker A
Mol Pharmacol; 2004 Oct; 66(4):870-9. PubMed ID: 15226414
[TBL] [Abstract][Full Text] [Related]
14. Differential PKC-dependent and -independent PKD activation by G protein α subunits of the Gq family: selective stimulation of PKD Ser⁷⁴⁸ autophosphorylation by Gαq.
Waldron RT; Innamorati G; Torres-Marquez ME; Sinnett-Smith J; Rozengurt E
Cell Signal; 2012 Apr; 24(4):914-21. PubMed ID: 22227248
[TBL] [Abstract][Full Text] [Related]
15. Pharmacology of the receptors for the phorbol ester tumor promoters: multiple receptors with different biochemical properties.
Kazanietz MG; Caloca MJ; Eroles P; Fujii T; García-Bermejo ML; Reilly M; Wang H
Biochem Pharmacol; 2000 Nov; 60(10):1417-24. PubMed ID: 11020443
[TBL] [Abstract][Full Text] [Related]
16. Ligand structure-activity requirements and phospholipid dependence for the binding of phorbol esters to protein kinase D.
Wang QJ; Fang TW; Yang D; Lewin NE; Van Lint J; Marquez VE; Blumberg PM
Mol Pharmacol; 2003 Dec; 64(6):1342-8. PubMed ID: 14645664
[TBL] [Abstract][Full Text] [Related]
17. Expression and phorbol ester-induced down-regulation of protein kinase C isozymes in osteoblasts.
Sanders JL; Stern PH
J Bone Miner Res; 1996 Dec; 11(12):1862-72. PubMed ID: 8970887
[TBL] [Abstract][Full Text] [Related]
18. The potential use of protein kinase D inhibitors for prevention/treatment of epidermal tumors.
Arun SN; Xie D; Dodd ME; Zhong X; Bollag WB
J Dermatol Sci; 2010 Oct; 60(1):29-39. PubMed ID: 20832999
[TBL] [Abstract][Full Text] [Related]
19. Loss of mouse epidermal protein kinase C isozyme activities following treatment with phorbol ester and non-phorbol ester tumor promoters.
Wang XJ; Warren BS; Rupp T; Beltrán LM; DiGiovanni J
Carcinogenesis; 1994 Dec; 15(12):2795-803. PubMed ID: 8001237
[TBL] [Abstract][Full Text] [Related]
20. Activation of protein kinase C subtypes alpha, gamma, delta, epsilon, zeta, and eta by tumor-promoting and nontumor-promoting agents.
Geiges D; Meyer T; Marte B; Vanek M; Weissgerber G; Stabel S; Pfeilschifter J; Fabbro D; Huwiler A
Biochem Pharmacol; 1997 Mar; 53(6):865-75. PubMed ID: 9113106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
